These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25218622)

  • 1. Rıvaroxaban-induced severe diffuse ıntracerebral hemorrhage.
    Çalışkan F; Akdemir HU; Nurata H; Akdemir N; Başara G; Yavuz Y
    Am J Emerg Med; 2015 Mar; 33(3):475.e1-5. PubMed ID: 25218622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening haemorrhagic pericarditis associated with rivaroxaban.
    Xu B; MacIsaac A
    Int J Cardiol; 2014 Jun; 174(2):e75-6. PubMed ID: 24794963
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral hemorrhage under rivaroxaban.
    Stöllberger C; Zuntner G; Bastovansky A; Finsterer J
    Int J Cardiol; 2013 Sep; 167(6):e179-81. PubMed ID: 23651821
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.
    Piccini JP; Garg J; Patel MR; Lokhnygina Y; Goodman SG; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Nessel CC; Mahaffey KW; Singer DE; Califf RM; Fox KA;
    Eur Heart J; 2014 Jul; 35(28):1873-80. PubMed ID: 24658769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Tamponade Associated with Rivaroxaban.
    Boone S
    Del Med J; 2015 Jul; 87(7):206-7. PubMed ID: 26285318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban 2.5 mg. No justification for using this anticoagulant after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):229-32. PubMed ID: 25964962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban in acute coronary syndromes--is it prime time?
    Asrar ul Haq M; van Gaal WJ
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):649-58. PubMed ID: 24746010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated hemopericardium associated with rivaroxaban: first case report.
    Shivamurthy P; Brar N; Therrien ML
    Pharmacotherapy; 2014 Sep; 34(9):e169-72. PubMed ID: 25074401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation.
    Kauffmann S; Chabanne R; Coste A; Longeras F; Sinegre T; Schmidt J; Samama CM; Constantin JM; Lebreton A
    A A Case Rep; 2015 Jun; 4(11):151-4. PubMed ID: 26035221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
    Gorzelak-Pabiś P; Duraj I; Szlagowska L; Ciastkowska A; Broncel M
    Pol Merkur Lekarski; 2014 Nov; 37(221):261-4. PubMed ID: 25546985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
    Sherid M; Sifuentes H; Sulaiman S; Samo S; Husein H; Tupper R; Thiruvaiyaru D; Spurr C; Sridhar S
    Digestion; 2014; 90(2):137-46. PubMed ID: 25278002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pericardial bleeding risk with non-vitamin K oral anticoagulants: a meta-analysis.
    Caldeira D; Barra M; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
    Int J Cardiol; 2015 Mar; 182():187-8. PubMed ID: 25577761
    [No Abstract]   [Full Text] [Related]  

  • 13. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
    Martínez-Rubio A; Dan GA; Kaski JC
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of rivaroxaban associated intracranial hemorrhage.
    Lo JC; Gerona RR
    West J Emerg Med; 2014 Jul; 15(4):375-7. PubMed ID: 25035736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary haemorrhage from therapeutic rivaroxaban use: chest radiograph consolidation is not always infection!
    Wong A; Koutsogiannis Z; Greene SL
    Emerg Med Australas; 2014 Jun; 26(3):318-9. PubMed ID: 24809972
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary hematoma expansion in intracerebral hemorrhage during rivaroxaban therapy.
    Purrucker JC; Capper D; Behrens L; Veltkamp R
    Am J Emerg Med; 2014 Aug; 32(8):947.e3-5. PubMed ID: 24602898
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.
    Zhou W; Zorn M; Nawroth P; Bütehorn U; Perzborn E; Heitmeier S; Veltkamp R
    Stroke; 2013 Mar; 44(3):771-8. PubMed ID: 23339956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous rectus sheath hematoma during rivaroxaban therapy.
    Kocayigit I; Can Y; Sahinkus S; Aydın E; Vatan MB; Kılıc H; Gunduz H
    Indian J Pharmacol; 2014; 46(3):339-40. PubMed ID: 24987185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
    Fenger-Eriksen C; Münster AM; Grove EL
    Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.